-
1
-
-
79954609211
-
Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition
-
Armstrong, J. L., Corazzari, M., Martin, S., Pagliarini, V., Falasca, L., Hill, D. S., Ellis, N., Al Sabah, S., Redfern, C. P., Fimia, G. M., Piacentini, M., and Lovat, P. E. (2011). Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clin. Cancer Res. 17, 2216-2226.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 2216-2226
-
-
Armstrong, J.L.1
Corazzari, M.2
Martin, S.3
Pagliarini, V.4
Falasca, L.5
Hill, D.S.6
Ellis, N.7
Al Sabah, S.8
Redfern, C.P.9
Fimia, G.M.10
Piacentini, M.11
Lovat, P.E.12
-
2
-
-
33750600634
-
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group
-
Oblimersen Melanoma Study Group.
-
Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., Kirkwood, J. M., Haluska, F. G., and Oblimersen Melanoma Study Group. (2006). Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J. Clin. Oncol. 24, 4738-4745.
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 4738-4745
-
-
Bedikian, A.Y.1
Millward, M.2
Pehamberger, H.3
Conry, R.4
Gore, M.5
Trefzer, U.6
Pavlick, A.C.7
DeConti, R.8
Hersh, E.M.9
Hersey, P.10
Kirkwood, J.M.11
Haluska, F.G.12
-
3
-
-
65549096830
-
Mcl-1 is required for melanoma cell resistance to anoikis
-
Boisvert-Adamo, K., Longmate, W., Abel, E. V., and Aplin, A. E. (2009). Mcl-1 is required for melanoma cell resistance to anoikis. Mol. Cancer Res. 7, 549-556.
-
(2009)
Mol. Cancer Res.
, vol.7
, pp. 549-556
-
-
Boisvert-Adamo, K.1
Longmate, W.2
Abel, E.V.3
Aplin, A.E.4
-
4
-
-
0033607506
-
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
-
Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., Adams, J. M., and Strasser, A. (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738.
-
(1999)
Science
, vol.286
, pp. 1735-1738
-
-
Bouillet, P.1
Metcalf, D.2
Huang, D.C.3
Tarlinton, D.M.4
Kay, T.W.5
Kontgen, F.6
Adams, J.M.7
Strasser, A.8
-
5
-
-
84866732329
-
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis
-
Cabello, C. M., Lamore, S. D., Bair, W. B. III, Qiao, S., Azimian, S., Lesson, J. L., and Wondrak, G. T. (2011). The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Invest. New Drugs 1-13.
-
(2011)
Invest. New Drugs
, pp. 1-13
-
-
Cabello, C.M.1
Lamore, S.D.2
Bair III, W.B.3
Qiao, S.4
Azimian, S.5
Lesson, J.L.6
Wondrak, G.T.7
-
6
-
-
52149107116
-
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival
-
Cartlidge, R. A., Thomas, G. R., Cagnol, S., Jong, K. A., Molton, S. A., Finch, A. J., and McMahon, M. (2008). Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival. Pigment Cell Melanoma Res. 21, 534-544.
-
(2008)
Pigment Cell Melanoma Res.
, vol.21
, pp. 534-544
-
-
Cartlidge, R.A.1
Thomas, G.R.2
Cagnol, S.3
Jong, K.A.4
Molton, S.A.5
Finch, A.J.6
McMahon, M.7
-
7
-
-
0032717587
-
Genes involved in melanoma: an overview of INK4a and other loci
-
Castellano, M., and Parmiani, G. (1999). Genes involved in melanoma: an overview of INK4a and other loci. Melanoma Res. 9, 421-432.
-
(1999)
Melanoma Res.
, vol.9
, pp. 421-432
-
-
Castellano, M.1
Parmiani, G.2
-
8
-
-
0028894034
-
bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi
-
Cerroni, L., Soyer, H. P., and Kerl, H. (1995). bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am. J. Dermatopathol. 17, 7-11.
-
(1995)
Am. J. Dermatopathol.
, vol.17
, pp. 7-11
-
-
Cerroni, L.1
Soyer, H.P.2
Kerl, H.3
-
9
-
-
4344660599
-
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis
-
Chawla-Sarkar, M., Bae, S. I., Reu, F. J., Jacobs, B. S., Lindner, D. J., and Borden, E. C. (2004). Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11, 915-923.
-
(2004)
Cell Death Differ.
, vol.11
, pp. 915-923
-
-
Chawla-Sarkar, M.1
Bae, S.I.2
Reu, F.J.3
Jacobs, B.S.4
Lindner, D.J.5
Borden, E.C.6
-
10
-
-
80055000875
-
miR-193b regulates Mcl-1 in melanoma
-
PMID: 21893020. [Epub ahead of print]
-
Chen, J., Zhang, X., Lentz, C., Abi-Daoud, M., Pare, G. C., Yang, X., Feilotter, H. E., and Tron, V. A. (2011). miR-193b regulates Mcl-1 in melanoma. Am. J. Pathol. PMID: 21893020. [Epub ahead of print].
-
(2011)
Am. J. Pathol.
-
-
Chen, J.1
Zhang, X.2
Lentz, C.3
Abi-Daoud, M.4
Pare, G.C.5
Yang, X.6
Feilotter, H.E.7
Tron, V.A.8
-
11
-
-
19944432123
-
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
-
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., and Huang, D. C. (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17, 393-403.
-
(2005)
Mol. Cell
, vol.17
, pp. 393-403
-
-
Chen, L.1
Willis, S.N.2
Wei, A.3
Smith, B.J.4
Fletcher, J.I.5
Hinds, M.G.6
Colman, P.M.7
Day, C.L.8
Adams, J.M.9
Huang, D.C.10
-
12
-
-
69349094578
-
Role and regulation of autophagy in cancer
-
Chen, N., and Karantza-Wadsworth, V. (2009). Role and regulation of autophagy in cancer. Biochim. Biophys. Acta 1793, 1516-1523.
-
(2009)
Biochim. Biophys. Acta
, vol.1793
, pp. 1516-1523
-
-
Chen, N.1
Karantza-Wadsworth, V.2
-
13
-
-
24644436766
-
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53
-
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., and Green, D. R. (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309, 1732-1735.
-
(2005)
Science
, vol.309
, pp. 1732-1735
-
-
Chipuk, J.E.1
Bouchier-Hayes, L.2
Kuwana, T.3
Newmeyer, D.D.4
Green, D.R.5
-
14
-
-
41149152733
-
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
-
Chipuk, J. E., and Green, D. R. (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18, 157-164.
-
(2008)
Trends Cell Biol.
, vol.18
, pp. 157-164
-
-
Chipuk, J.E.1
Green, D.R.2
-
15
-
-
0842278331
-
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
-
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., and Green, D. R. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014.
-
(2004)
Science
, vol.303
, pp. 1010-1014
-
-
Chipuk, J.E.1
Kuwana, T.2
Bouchier-Hayes, L.3
Droin, N.M.4
Newmeyer, D.D.5
Schuler, M.6
Green, D.R.7
-
16
-
-
75949105922
-
The BCL-2 family reunion
-
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., and Green, D. R. (2010). The BCL-2 family reunion. Mol. Cell 37, 299-310.
-
(2010)
Mol. Cell
, vol.37
, pp. 299-310
-
-
Chipuk, J.E.1
Moldoveanu, T.2
Llambi, F.3
Parsons, M.J.4
Green, D.R.5
-
17
-
-
0028861903
-
Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma
-
Collins, K. A., and White, W. L. (1995). Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma. Am. J. Dermatopathol. 17, 429-438.
-
(1995)
Am. J. Dermatopathol.
, vol.17
, pp. 429-438
-
-
Collins, K.A.1
White, W.L.2
-
18
-
-
55849139095
-
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
-
Cragg, M. S., Jansen, E. S., Cook, M., Harris, C., Strasser, A., and Scott, C. L. (2008). Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic. J. Clin. Invest. 118, 3651-3659.
-
(2008)
J. Clin. Invest.
, vol.118
, pp. 3651-3659
-
-
Cragg, M.S.1
Jansen, E.S.2
Cook, M.3
Harris, C.4
Strasser, A.5
Scott, C.L.6
-
19
-
-
38149096186
-
Bim expression is reduced in human cutaneous melanomas
-
Dai, D. L., Wang, Y., Liu, M., Martinka, M., and Li, G. (2008). Bim expression is reduced in human cutaneous melanomas. J. Invest. Dermatol. 128, 403-407.
-
(2008)
J. Invest. Dermatol.
, vol.128
, pp. 403-407
-
-
Dai, D.L.1
Wang, Y.2
Liu, M.3
Martinka, M.4
Li, G.5
-
20
-
-
65649147543
-
Braf (V600E) cooperates with Pten loss to induce metastatic melanoma
-
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky, W. E. Jr., You, M. J., DePinho, R. A., McMahon, M., and Bosenberg, M. (2009). Braf (V600E) cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 41, 544-552.
-
(2009)
Nat. Genet.
, vol.41
, pp. 544-552
-
-
Dankort, D.1
Curley, D.P.2
Cartlidge, R.A.3
Nelson, B.4
Karnezis, A.N.5
Damsky Jr., W.E.6
You, M.J.7
DePinho, R.A.8
McMahon, M.9
Bosenberg, M.10
-
21
-
-
18444374405
-
Mutations of the BRAF gene in human cancer
-
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
-
(2002)
Nature
, vol.417
, pp. 949-954
-
-
Davies, H.1
Bignell, G.R.2
Cox, C.3
Stephens, P.4
Edkins, S.5
Clegg, S.6
Teague, J.7
Woffendin, H.8
Garnett, M.J.9
Bottomley, W.10
Davis, N.11
Dicks, E.12
Ewing, R.13
Floyd, Y.14
Gray, K.15
Hall, S.16
Hawes, R.17
Hughes, J.18
Kosmidou, V.19
Menzies, A.20
Mould, C.21
Parker, A.22
Stevens, C.23
Watt, S.24
Hooper, S.25
Wilson, R.26
Jayatilake, H.27
Gusterson, B.A.28
Cooper, C.29
Shipley, J.30
Hargrave, D.31
Pritchard-Jones, K.32
Maitland, N.33
Chenevix-Trench, G.34
Riggins, G.J.35
Bigner, D.D.36
Palmieri, G.37
Cossu, A.38
Flanagan, A.39
Nicholson, A.40
Ho, J.W.41
Leung, S.Y.42
Yuen, S.T.43
Weber, B.L.44
Seigler, H.F.45
Darrow, T.L.46
Paterson, H.47
Marais, R.48
Marshall, C.J.49
Wooster, R.50
Stratton, M.R.51
Futreal, P.A.52
more..
-
22
-
-
33745984839
-
The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes
-
de la Serna, I. L., Ohkawa, Y., Higashi, C., Dutta, C., Osias, J., Kommajosyula, N., Tachibana, T., and Imbalzano, A. N. (2006). The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J. Biol. Chem. 281, 20233-20241.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 20233-20241
-
-
de la Serna, I.L.1
Ohkawa, Y.2
Higashi, C.3
Dutta, C.4
Osias, J.5
Kommajosyula, N.6
Tachibana, T.7
Imbalzano, A.N.8
-
23
-
-
0348014548
-
Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity
-
Del Bufalo, D., Trisciuoglio, D., Scarsella, M., Zangemeister-Wittke, U., and Zupi, G. (2003). Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity. Oncogene 22, 8441-8447.
-
(2003)
Oncogene
, vol.22
, pp. 8441-8447
-
-
Del Bufalo, D.1
Trisciuoglio, D.2
Scarsella, M.3
Zangemeister-Wittke, U.4
Zupi, G.5
-
24
-
-
34547603628
-
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
-
Deng, J., Carlson, N., Takeyama, K., Dal Cin, P., Shipp, M., and Letai, A. (2007). BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12, 171-185.
-
(2007)
Cancer Cell
, vol.12
, pp. 171-185
-
-
Deng, J.1
Carlson, N.2
Takeyama, K.3
Dal Cin, P.4
Shipp, M.5
Letai, A.6
-
25
-
-
70449941949
-
Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices
-
Dewson, G., Kratina, T., Czabotar, P., Day, C. L., Adams, J. M., and Kluck, R. M. (2009). Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol. Cell 36, 696-703.
-
(2009)
Mol. Cell
, vol.36
, pp. 696-703
-
-
Dewson, G.1
Kratina, T.2
Czabotar, P.3
Day, C.L.4
Adams, J.M.5
Kluck, R.M.6
-
26
-
-
43049105074
-
To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3: groove interactions
-
Dewson, G., Kratina, T., Sim, H. W., Puthalakath, H., Adams, J. M., Colman, P. M., and Kluck, R. M. (2008). To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3: groove interactions. Mol. Cell 30, 369-380.
-
(2008)
Mol. Cell
, vol.30
, pp. 369-380
-
-
Dewson, G.1
Kratina, T.2
Sim, H.W.3
Puthalakath, H.4
Adams, J.M.5
Colman, P.M.6
Kluck, R.M.7
-
27
-
-
80052074729
-
Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress
-
Dong, L., Jiang, C. C., Thorne, R. F., Croft, A., Yang, F., Liu, H., de Bock, C. E., Hersey, P., and Zhang, X. D. (2011). Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. Oncogene 30, 3716-3726.
-
(2011)
Oncogene
, vol.30
, pp. 3716-3726
-
-
Dong, L.1
Jiang, C.C.2
Thorne, R.F.3
Croft, A.4
Yang, F.5
Liu, H.6
de Bock, C.E.7
Hersey, P.8
Zhang, X.D.9
-
28
-
-
33749252583
-
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
-
Eckelman, B. P., Salvesen, G. S., and Scott, F. L. (2006). Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988-994.
-
(2006)
EMBO Rep.
, vol.7
, pp. 988-994
-
-
Eckelman, B.P.1
Salvesen, G.S.2
Scott, F.L.3
-
29
-
-
33845592531
-
NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing
-
Edlundh-Rose, E., Egyhazi, S., Omholt, K., Mansson-Brahme, E., Platz, A., Hansson, J., and Lundeberg, J. (2006). NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16, 471-478.
-
(2006)
Melanoma Res.
, vol.16
, pp. 471-478
-
-
Edlundh-Rose, E.1
Egyhazi, S.2
Omholt, K.3
Mansson-Brahme, E.4
Platz, A.5
Hansson, J.6
Lundeberg, J.7
-
30
-
-
79953306808
-
Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival
-
Elgendy, M., Sheridan, C., Brumatti, G., and Martin, S. J. (2011). Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 42, 23-35.
-
(2011)
Mol. Cell
, vol.42
, pp. 23-35
-
-
Elgendy, M.1
Sheridan, C.2
Brumatti, G.3
Martin, S.J.4
-
31
-
-
38649083722
-
Immunohistochemical detection of XIAP in melanoma
-
Emanuel, P. O., Phelps, R. G., Mudgil, A., Shafir, M., and Burstein, D. E. (2008). Immunohistochemical detection of XIAP in melanoma. J. Cutan. Pathol. 35, 292-297.
-
(2008)
J. Cutan. Pathol.
, vol.35
, pp. 292-297
-
-
Emanuel, P.O.1
Phelps, R.G.2
Mudgil, A.3
Shafir, M.4
Burstein, D.E.5
-
32
-
-
33745583838
-
Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis
-
Fecker, L. F., Geilen, C. C., Tchernev, G., Trefzer, U., Assaf, C., Kurbanov, B. M., Schwarz, C., Daniel, P. T., and Eberle, J. (2006). Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis. J. Invest. Dermatol. 126, 1366-1371.
-
(2006)
J. Invest. Dermatol.
, vol.126
, pp. 1366-1371
-
-
Fecker, L.F.1
Geilen, C.C.2
Tchernev, G.3
Trefzer, U.4
Assaf, C.5
Kurbanov, B.M.6
Schwarz, C.7
Daniel, P.T.8
Eberle, J.9
-
33
-
-
22244454745
-
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications
-
Fernandez, Y., Verhaegen, M., Miller, T. P., Rush, J. L., Steiner, P., Opipari, A. W. Jr., Lowe, S. W., and Soengas, M. S. (2005). Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res. 65, 6294-6304.
-
(2005)
Cancer Res.
, vol.65
, pp. 6294-6304
-
-
Fernandez, Y.1
Verhaegen, M.2
Miller, T.P.3
Rush, J.L.4
Steiner, P.5
Opipari Jr., A.W.6
Lowe, S.W.7
Soengas, M.S.8
-
34
-
-
77956030786
-
Inhibition of mutated, activated BRAF in metastatic melanoma
-
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., and Chapman, P. B. (2010). Inhibition of mutated, activated BRAF in metastatic melanoma. N. Engl. J. Med. 363, 809-819.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 809-819
-
-
Flaherty, K.T.1
Puzanov, I.2
Kim, K.B.3
Ribas, A.4
McArthur, G.A.5
Sosman, J.A.6
O'Dwyer, P.J.7
Lee, R.J.8
Grippo, J.F.9
Nolop, K.10
Chapman, P.B.11
-
35
-
-
55949083407
-
Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment
-
Fong, L., and Small, E. J. (2008). Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment. J. Clin. Oncol. 26, 5275-5283.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 5275-5283
-
-
Fong, L.1
Small, E.J.2
-
36
-
-
0035925537
-
Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins
-
Gautschi, O., Tschopp, S., Olie, R. A., Leech, S. H., Simoes-Wust, A. P., Ziegler, A., Baumann, B., Odermatt, B., Hall, J., Stahel, R. A., and Zangemeister-Wittke, U. (2001). Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. J. Natl. Cancer Inst. 93, 463-471.
-
(2001)
J. Natl. Cancer Inst.
, vol.93
, pp. 463-471
-
-
Gautschi, O.1
Tschopp, S.2
Olie, R.A.3
Leech, S.H.4
Simoes-Wust, A.P.5
Ziegler, A.6
Baumann, B.7
Odermatt, B.8
Hall, J.9
Stahel, R.A.10
Zangemeister-Wittke, U.11
-
37
-
-
78149449341
-
BH3-triggered structural reorganization drives the activation of proapoptotic BAX
-
Gavathiotis, E., Reyna, D. E., Davis, M. L., Bird, G. H., and Walensky, L. D. (2010). BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol. Cell 40, 481-492.
-
(2010)
Mol. Cell
, vol.40
, pp. 481-492
-
-
Gavathiotis, E.1
Reyna, D.E.2
Davis, M.L.3
Bird, G.H.4
Walensky, L.D.5
-
38
-
-
54549114986
-
BAX activation is initiated at a novel interaction site
-
Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H. C., Kim, H., Cheng, E. H., Tjandra, N., and Walensky, L. D. (2008). BAX activation is initiated at a novel interaction site. Nature 455, 1076-1081.
-
(2008)
Nature
, vol.455
, pp. 1076-1081
-
-
Gavathiotis, E.1
Suzuki, M.2
Davis, M.L.3
Pitter, K.4
Bird, G.H.5
Katz, S.G.6
Tu, H.C.7
Kim, H.8
Cheng, E.H.9
Tjandra, N.10
Walensky, L.D.11
-
39
-
-
58549092250
-
Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells
-
Goldstein, N. B., Johannes, W. U., Gadeliya, A. V., Green, M. R., Fujita, M., Norris, D. A., and Shellman, Y. G. (2009). Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells. J. Invest. Dermatol. 129, 432-437.
-
(2009)
J. Invest. Dermatol.
, vol.129
, pp. 432-437
-
-
Goldstein, N.B.1
Johannes, W.U.2
Gadeliya, A.V.3
Green, M.R.4
Fujita, M.5
Norris, D.A.6
Shellman, Y.G.7
-
40
-
-
0037440238
-
Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients
-
Gradilone, A., Gazzaniga, P., Ribuffo, D., Scarpa, S., Cigna, E., Vasaturo, F., Bottoni, U., Innocenzi, D., Calvieri, S., Scuderi, N., Frati, L., and Aglianò, A. M. (2003). Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. J. Clin. Oncol. 21, 306-312.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 306-312
-
-
Gradilone, A.1
Gazzaniga, P.2
Ribuffo, D.3
Scarpa, S.4
Cigna, E.5
Vasaturo, F.6
Bottoni, U.7
Innocenzi, D.8
Calvieri, S.9
Scuderi, N.10
Frati, L.11
Aglianò, A.M.12
-
41
-
-
0036463405
-
A matter of life and death
-
Green, D. R., and Evan, G. I. (2002). A matter of life and death. Cancer Cell 1, 19-30.
-
(2002)
Cancer Cell
, vol.1
, pp. 19-30
-
-
Green, D.R.1
Evan, G.I.2
-
42
-
-
0029748608
-
Bcl-2 expression in malignant melanoma and its prognostic significance
-
Grover, R., and Wilson, G. D. (1996). Bcl-2 expression in malignant melanoma and its prognostic significance. Eur. J. Surg. Oncol. 22, 347-349.
-
(1996)
Eur. J. Surg. Oncol.
, vol.22
, pp. 347-349
-
-
Grover, R.1
Wilson, G.D.2
-
43
-
-
67649386107
-
Life and death by death receptors
-
Guicciardi, M. E., and Gores, G. J. (2009). Life and death by death receptors. FASEB J. 23, 1625-1637.
-
(2009)
FASEB J.
, vol.23
, pp. 1625-1637
-
-
Guicciardi, M.E.1
Gores, G.J.2
-
44
-
-
79952228407
-
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
-
Guo, J. Y., Chen, H. Y., Mathew, R., Fan, J., Strohecker, A. M., Karsli-Uzunbas, G., Kamphorst, J. J., Chen, G., Lemons, J. M., Karantza, V., Coller, H. A., Dipaola, R. S., Gelinas, C., Rabinowitz, J. D., and White, E. (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460-470.
-
(2011)
Genes Dev.
, vol.25
, pp. 460-470
-
-
Guo, J.Y.1
Chen, H.Y.2
Mathew, R.3
Fan, J.4
Strohecker, A.M.5
Karsli-Uzunbas, G.6
Kamphorst, J.J.7
Chen, G.8
Lemons, J.M.9
Karantza, V.10
Coller, H.A.11
Dipaola, R.S.12
Gelinas, C.13
Rabinowitz, J.D.14
White, E.15
-
45
-
-
0031894534
-
Molecular genetics of familial cutaneous melanoma
-
Haluska, F. G., and Hodi, F. S. (1998). Molecular genetics of familial cutaneous melanoma. J. Clin. Oncol. 16, 670-682.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 670-682
-
-
Haluska, F.G.1
Hodi, F.S.2
-
46
-
-
79958242724
-
Induction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells
-
Hamsa, T. P., Thejass, P., and Kuttan, G. (2011). Induction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells. Drug Chem. Toxicol. 34, 332-340.
-
(2011)
Drug Chem. Toxicol.
, vol.34
, pp. 332-340
-
-
Hamsa, T.P.1
Thejass, P.2
Kuttan, G.3
-
47
-
-
77955712441
-
Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy
-
Hiscutt, E. L., Hill, D. S., Martin, S., Kerr, R., Harbottle, A., Birch-Machin, M., Redfern, C. P., Fulda, S., Armstrong, J. L., and Lovat, P. E. (2010). Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy. J. Invest. Dermatol. 130, 2250-2258.
-
(2010)
J. Invest. Dermatol.
, vol.130
, pp. 2250-2258
-
-
Hiscutt, E.L.1
Hill, D.S.2
Martin, S.3
Kerr, R.4
Harbottle, A.5
Birch-Machin, M.6
Redfern, C.P.7
Fulda, S.8
Armstrong, J.L.9
Lovat, P.E.10
-
48
-
-
34248375532
-
Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants
-
Hocker, T., and Tsao, H. (2007). Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum. Mutat. 28, 578-588.
-
(2007)
Hum. Mutat.
, vol.28
, pp. 578-588
-
-
Hocker, T.1
Tsao, H.2
-
49
-
-
53949103143
-
Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside
-
Hocker, T. L., Singh, M. K., and Tsao, H. (2008). Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside. J. Invest. Dermatol. 128, 2575-2595.
-
(2008)
J. Invest. Dermatol.
, vol.128
, pp. 2575-2595
-
-
Hocker, T.L.1
Singh, M.K.2
Tsao, H.3
-
50
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., Akerley, W., van den Eertwegh, A. J., Lutzky, J., Lorigan, P., Vaubel, J. M., Linette, G. P., Hogg, D., Ottensmeier, C. H., Lebbé, C., Peschel, C., Quirt, I., Clark, J. I., Wolchok, J. D., Weber, J. S., Tian, J., Yellin, M. J., Nichol, G. M., Hoos, A., and Urba, W. J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
Gonzalez, R.7
Robert, C.8
Schadendorf, D.9
Hassel, J.C.10
Akerley, W.11
van den Eertwegh, A.J.12
Lutzky, J.13
Lorigan, P.14
Vaubel, J.M.15
Linette, G.P.16
Hogg, D.17
Ottensmeier, C.H.18
Lebbé, C.19
Peschel, C.20
Quirt, I.21
Clark, J.I.22
Wolchok, J.D.23
Weber, J.S.24
Tian, J.25
Yellin, M.J.26
Nichol, G.M.27
Hoos, A.28
Urba, W.J.29
more..
-
51
-
-
0031007644
-
Nonionic detergents induce dimerization among members of the Bcl-2 family
-
Hsu, Y. T., and Youle, R. J. (1997). Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272, 13829-13834.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 13829-13834
-
-
Hsu, Y.T.1
Youle, R.J.2
-
52
-
-
66149090765
-
Molecular pathogenesis of cutaneous melanocytic neoplasms
-
Ibrahim, N., and Haluska, F. G. (2009). Molecular pathogenesis of cutaneous melanocytic neoplasms. Annu. Rev. Pathol. 4, 551-579.
-
(2009)
Annu. Rev. Pathol.
, vol.4
, pp. 551-579
-
-
Ibrahim, N.1
Haluska, F.G.2
-
53
-
-
0036547417
-
Death and anti-death: tumour resistance to apoptosis
-
Igney, F. H., and Krammer, P. H. (2002). Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277-288.
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 277-288
-
-
Igney, F.H.1
Krammer, P.H.2
-
54
-
-
0031907428
-
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
-
Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., van Elsas, A., Muller, M., Wolff, K., Eichler, H. G., and Pehamberger, H. (1998). bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med. 4, 232-234.
-
(1998)
Nat. Med.
, vol.4
, pp. 232-234
-
-
Jansen, B.1
Schlagbauer-Wadl, H.2
Brown, B.D.3
Bryan, R.N.4
van Elsas, A.5
Muller, M.6
Wolff, K.7
Eichler, H.G.8
Pehamberger, H.9
-
55
-
-
0034684471
-
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
-
Jansen, B., Wacheck, V., Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., and Pehamberger, H. (2000). Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356, 1728-1733.
-
(2000)
Lancet
, vol.356
, pp. 1728-1733
-
-
Jansen, B.1
Wacheck, V.2
Heere-Ress, E.3
Schlagbauer-Wadl, H.4
Hoeller, C.5
Lucas, T.6
Hoermann, M.7
Hollenstein, U.8
Wolff, K.9
Pehamberger, H.10
-
56
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249.
-
(2009)
CA Cancer J. Clin.
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
57
-
-
79951818357
-
Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS
-
Jiang, C. C., Lai, F., Tay, K. H., Croft, A., Rizos, H., Becker, T. M., Yang, F., Liu, H., Thorne, R. F., Hersey, P., and Zhang, X. D. (2010a). Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis. 1, e69.
-
(2010)
Cell Death Dis.
, vol.1
-
-
Jiang, C.C.1
Lai, F.2
Tay, K.H.3
Croft, A.4
Rizos, H.5
Becker, T.M.6
Yang, F.7
Liu, H.8
Thorne, R.F.9
Hersey, P.10
Zhang, X.D.11
-
58
-
-
77953364119
-
Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis
-
Jiang, G., Liu, Y. Q., Wei, Z. P., Pei, D. S., Mao, L. J., and Zheng, J. N. (2010b). Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer Lett. 294, 220-228.
-
(2010)
Cancer Lett.
, vol.294
, pp. 220-228
-
-
Jiang, G.1
Liu, Y.Q.2
Wei, Z.P.3
Pei, D.S.4
Mao, L.J.5
Zheng, J.N.6
-
59
-
-
53049105459
-
Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress
-
Jiang, C. C., Lucas, K., Avery-Kiejda, K. A., Wade, M., deBock, C. E., Thorne, R. F., Allen, J., Hersey, P., and Zhang, X. D. (2008). Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res. 68, 6708-6717.
-
(2008)
Cancer Res.
, vol.68
, pp. 6708-6717
-
-
Jiang, C.C.1
Lucas, K.2
Avery-Kiejda, K.A.3
Wade, M.4
deBock, C.E.5
Thorne, R.F.6
Allen, J.7
Hersey, P.8
Zhang, X.D.9
-
60
-
-
69249139451
-
Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax
-
Jiang, C. C., Wroblewski, D., Yang, F., Hersey, P., and Zhang, X. D. (2009). Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax. Neoplasia 11, 945-955.
-
(2009)
Neoplasia
, vol.11
, pp. 945-955
-
-
Jiang, C.C.1
Wroblewski, D.2
Yang, F.3
Hersey, P.4
Zhang, X.D.5
-
61
-
-
80053139025
-
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
-
Jin, L., Hu, W. L., Jiang, C. C., Wang, J. X., Han, C. C., Chu, P., Zhang, L. J., Thorne, R. F., Wilmott, J., Scolyer, R. A., Hersey, P., Zhang, X. D., and Wu, M. (2011). MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc. Natl. Acad. Sci. U.S.A. 108, 15840-15845.
-
(2011)
Proc. Natl. Acad. Sci. U.S.A.
, vol.108
, pp. 15840-15845
-
-
Jin, L.1
Hu, W.L.2
Jiang, C.C.3
Wang, J.X.4
Han, C.C.5
Chu, P.6
Zhang, L.J.7
Thorne, R.F.8
Wilmott, J.9
Scolyer, R.A.10
Hersey, P.11
Zhang, X.D.12
Wu, M.13
-
62
-
-
78650816688
-
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
-
Kapoor, A., Goldberg, M. S., Cumberland, L. K., Ratnakumar, K., Segura, M. F., Emanuel, P. O., Menendez, S., Vardabasso, C., Leroy, G., Vidal, C. I., Polsky, D., Osman, I., Garcia, B. A., Hernando, E., and Bernstein, E. (2010). The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468, 1105-1109.
-
(2010)
Nature
, vol.468
, pp. 1105-1109
-
-
Kapoor, A.1
Goldberg, M.S.2
Cumberland, L.K.3
Ratnakumar, K.4
Segura, M.F.5
Emanuel, P.O.6
Menendez, S.7
Vardabasso, C.8
Leroy, G.9
Vidal, C.I.10
Polsky, D.11
Osman, I.12
Garcia, B.A.13
Hernando, E.14
Bernstein, E.15
-
63
-
-
40649126759
-
mTOR is activated in the majority of malignant melanomas
-
Karbowniczek, M., Spittle, C. S., Morrison, T., Wu, H., and Henske, E. P. (2008). mTOR is activated in the majority of malignant melanomas. J. Invest. Dermatol. 128, 980-987.
-
(2008)
J. Invest. Dermatol.
, vol.128
, pp. 980-987
-
-
Karbowniczek, M.1
Spittle, C.S.2
Morrison, T.3
Wu, H.4
Henske, E.P.5
-
64
-
-
73849126977
-
Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma
-
Keenen, B., Qi, H., Saladi, S. V., Yeung, M., and de la Serna, I. L. (2010). Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma. Oncogene 29, 81-92.
-
(2010)
Oncogene
, vol.29
, pp. 81-92
-
-
Keenen, B.1
Qi, H.2
Saladi, S.V.3
Yeung, M.4
de la Serna, I.L.5
-
65
-
-
77952559110
-
Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA
-
Keuling, A. M., Andrew, S. E., and Tron, V. A. (2010). Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA. Pigment Cell Melanoma Res. 23, 430-440.
-
(2010)
Pigment Cell Melanoma Res.
, vol.23
, pp. 430-440
-
-
Keuling, A.M.1
Andrew, S.E.2
Tron, V.A.3
-
66
-
-
68949099384
-
RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway
-
doi: 10.1371/journal.pone.0006651
-
Keuling, A. M., Felton, K. E., Parker, A. A., Akbari, M., Andrew, S. E., and Tron, V. A. (2009). RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway. PLoS ONE 4, e6651. doi: 10.1371/journal.pone.0006651
-
(2009)
PLoS ONE
, vol.4
-
-
Keuling, A.M.1
Felton, K.E.2
Parker, A.A.3
Akbari, M.4
Andrew, S.E.5
Tron, V.A.6
-
67
-
-
0035794204
-
Interleukin-3 withdrawal induces an early increase in mitochondrial membrane potential unrelated to the Bcl-2 family. Roles of intracellular pH, ADP transport, and F(0)F(1)-ATPase
-
Khaled, A. R., Reynolds, D. A., Young, H. A., Thompson, C. B., Muegge, K., and Durum, S. K. (2001). Interleukin-3 withdrawal induces an early increase in mitochondrial membrane potential unrelated to the Bcl-2 family. Roles of intracellular pH, ADP transport, and F(0)F(1)-ATPase. J. Biol. Chem. 276, 6453-6462.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 6453-6462
-
-
Khaled, A.R.1
Reynolds, D.A.2
Young, H.A.3
Thompson, C.B.4
Muegge, K.5
Durum, S.K.6
-
68
-
-
69249144800
-
Melanoma proliferation and chemoresistance controlled by the DEK oncogene
-
Khodadoust, M. S., Verhaegen, M., Kappes, F., Riveiro-Falkenbach, E., Cigudosa, J. C., Kim, D. S., Chinnaiyan, A. M., Markovitz, D. M., and Soengas, M. S. (2009). Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res. 69, 6405-6413.
-
(2009)
Cancer Res.
, vol.69
, pp. 6405-6413
-
-
Khodadoust, M.S.1
Verhaegen, M.2
Kappes, F.3
Riveiro-Falkenbach, E.4
Cigudosa, J.C.5
Kim, D.S.6
Chinnaiyan, A.M.7
Markovitz, D.M.8
Soengas, M.S.9
-
69
-
-
70449091753
-
Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis
-
Kim, H., Tu, H. C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J., and Cheng, E. H. (2009). Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 36, 487-499.
-
(2009)
Mol. Cell
, vol.36
, pp. 487-499
-
-
Kim, H.1
Tu, H.C.2
Ren, D.3
Takeuchi, O.4
Jeffers, J.R.5
Zambetti, G.P.6
Hsieh, J.J.7
Cheng, E.H.8
-
70
-
-
79952090075
-
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
-
Kim, M. (2010). Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Small Gtpases 1, 161-164.
-
(2010)
Small Gtpases
, vol.1
, pp. 161-164
-
-
Kim, M.1
-
71
-
-
33846973344
-
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization
-
Kluger, H. M., McCarthy, M. M., Alvero, A. B., Sznol, M., Ariyan, S., Camp, R. L., Rimm, D. L., and Mor, G. (2007). The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization. J. Transl. Med. 5, 6.
-
(2007)
J. Transl. Med.
, vol.5
, pp. 6
-
-
Kluger, H.M.1
McCarthy, M.M.2
Alvero, A.B.3
Sznol, M.4
Ariyan, S.5
Camp, R.L.6
Rimm, D.L.7
Mor, G.8
-
72
-
-
31544455853
-
Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma
-
Kobayashi, Y., Ohtsuki, M., Murakami, T., Kobayashi, T., Sutheesophon, K., Kitayama, H., Kano, Y., Kusano, E., Nakagawa, H., and Furukawa, Y. (2006). Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma. Oncogene 25, 512-524.
-
(2006)
Oncogene
, vol.25
, pp. 512-524
-
-
Kobayashi, Y.1
Ohtsuki, M.2
Murakami, T.3
Kobayashi, T.4
Sutheesophon, K.5
Kitayama, H.6
Kano, Y.7
Kusano, E.8
Nakagawa, H.9
Furukawa, Y.10
-
73
-
-
25444440875
-
The role of autophagy in cancer development and response to therapy
-
Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. (2005). The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 5, 726-734.
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 726-734
-
-
Kondo, Y.1
Kanzawa, T.2
Sawaya, R.3
Kondo, S.4
-
74
-
-
44849133234
-
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
-
Konopleva, M., Watt, J., Contractor, R., Tsao, T., Harris, D., Estrov, Z., Bornmann, W., Kantarjian, H., Viallet, J., Samudio, I., and Andreeff, M. (2008). Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax). Cancer Res. 68, 3413-3420.
-
(2008)
Cancer Res.
, vol.68
, pp. 3413-3420
-
-
Konopleva, M.1
Watt, J.2
Contractor, R.3
Tsao, T.4
Harris, D.5
Estrov, Z.6
Bornmann, W.7
Kantarjian, H.8
Viallet, J.9
Samudio, I.10
Andreeff, M.11
-
75
-
-
0032958922
-
Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation
-
Korabiowska, M., Brinck, U., Ruschenburg, I., Schlott, T., Droese, M., and Stachura, J. (1999). Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation. Pol. J. Pathol. 50, 17-21.
-
(1999)
Pol. J. Pathol.
, vol.50
, pp. 17-21
-
-
Korabiowska, M.1
Brinck, U.2
Ruschenburg, I.3
Schlott, T.4
Droese, M.5
Stachura, J.6
-
76
-
-
13944277343
-
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly
-
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., and Newmeyer, D. D. (2005). BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 17, 525-535.
-
(2005)
Mol. Cell
, vol.17
, pp. 525-535
-
-
Kuwana, T.1
Bouchier-Hayes, L.2
Chipuk, J.E.3
Bonzon, C.4
Sullivan, B.A.5
Green, D.R.6
Newmeyer, D.D.7
-
77
-
-
0036850312
-
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane
-
Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., and Newmeyer, D. D. (2002). Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342.
-
(2002)
Cell
, vol.111
, pp. 331-342
-
-
Kuwana, T.1
Mackey, M.R.2
Perkins, G.3
Ellisman, M.H.4
Latterich, M.5
Schneiter, R.6
Green, D.R.7
Newmeyer, D.D.8
-
78
-
-
0029097550
-
Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up
-
Lattanzi, S. C., Tosteson, T., Chertoff, J., Maurer, L. H., O'Donnell, J., LeMarbre, P. J., Mott, L., DelPrete, S. A., Forcier, R. J., and Ernstoff, M. S. (1995). Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. Melanoma Res. 5, 365-369.
-
(1995)
Melanoma Res.
, vol.5
, pp. 365-369
-
-
Lattanzi, S.C.1
Tosteson, T.2
Chertoff, J.3
Maurer, L.H.4
O'Donnell, J.5
LeMarbre, P.J.6
Mott, L.7
DelPrete, S.A.8
Forcier, R.J.9
Ernstoff, M.S.10
-
79
-
-
0029906912
-
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha
-
Legha, S. S., Ring, S., Bedikian, A., Plager, C., Eton, O., Buzaid, A. C., and Papadopoulos, N. (1996). Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Ann. Oncol. 7, 827-835.
-
(1996)
Ann. Oncol.
, vol.7
, pp. 827-835
-
-
Legha, S.S.1
Ring, S.2
Bedikian, A.3
Plager, C.4
Eton, O.5
Buzaid, A.C.6
Papadopoulos, N.7
-
80
-
-
0024448792
-
A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma
-
Legha, S. S., Ring, S., Papadopoulos, N., Plager, C., Chawla, S., and Benjamin, R. (1989). A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer 64, 2024-2029.
-
(1989)
Cancer
, vol.64
, pp. 2024-2029
-
-
Legha, S.S.1
Ring, S.2
Papadopoulos, N.3
Plager, C.4
Chawla, S.5
Benjamin, R.6
-
81
-
-
0034062695
-
Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
-
Leiter, U., Schmid, R. M., Kaskel, P., Peter, R. U., and Krahn, G. (2000). Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma. Arch. Dermatol. Res. 292, 225-232.
-
(2000)
Arch. Dermatol. Res.
, vol.292
, pp. 225-232
-
-
Leiter, U.1
Schmid, R.M.2
Kaskel, P.3
Peter, R.U.4
Krahn, G.5
-
82
-
-
0036728834
-
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
-
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., and Korsmeyer, S. J. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192.
-
(2002)
Cancer Cell
, vol.2
, pp. 183-192
-
-
Letai, A.1
Bassik, M.C.2
Walensky, L.D.3
Sorcinelli, M.D.4
Weiler, S.5
Korsmeyer, S.J.6
-
83
-
-
38549145044
-
Diagnosing and exploiting cancer's addiction to blocks in apoptosis
-
Letai, A. G. (2008). Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat. Rev. Cancer 8, 121-132.
-
(2008)
Nat. Rev. Cancer
, vol.8
, pp. 121-132
-
-
Letai, A.G.1
-
84
-
-
48249092267
-
Bcl-2 family members: dual regulators of apoptosis and autophagy
-
Levine, B., Sinha, S., and Kroemer, G. (2008). Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4, 600-606.
-
(2008)
Autophagy
, vol.4
, pp. 600-606
-
-
Levine, B.1
Sinha, S.2
Kroemer, G.3
-
85
-
-
0030715323
-
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
-
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
-
(1997)
Cell
, vol.91
, pp. 479-489
-
-
Li, P.1
Nijhawan, D.2
Budihardjo, I.3
Srinivasula, S.M.4
Ahmad, M.5
Alnemri, E.S.6
Wang, X.7
-
86
-
-
34347226747
-
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines
-
Lillehammer, T., Engesaeter, B. O., Prasmickaite, L., Maelandsmo, G. M., Fodstad, O., and Engebraaten, O. (2007). Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. J. Gene Med. 9, 440-451.
-
(2007)
J. Gene Med.
, vol.9
, pp. 440-451
-
-
Lillehammer, T.1
Engesaeter, B.O.2
Prasmickaite, L.3
Maelandsmo, G.M.4
Fodstad, O.5
Engebraaten, O.6
-
87
-
-
0034508217
-
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues
-
Lindsten, T., Ross, A. J., King, A., Zong, W. X., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K., Chen, Y., Wei, M., Eng, V. M., Adelman, D. M., Simon, M.C., Ma, A., Golden, J. A., Evan, G., Korsmeyer, S. J., MacGregor, G. R., and Thompson, C. B. (2000). The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399.
-
(2000)
Mol. Cell
, vol.6
, pp. 1389-1399
-
-
Lindsten, T.1
Ross, A.J.2
King, A.3
Zong, W.X.4
Rathmell, J.C.5
Shiels, H.A.6
Ulrich, E.7
Waymire, K.G.8
Mahar, P.9
Frauwirth, K.10
Chen, Y.11
Wei, M.12
Eng, V.M.13
Adelman, D.M.14
Simon, M.C.15
Ma, A.16
Golden, J.A.17
Evan, G.18
Korsmeyer, S.J.19
MacGregor, G.R.20
Thompson, C.B.21
more..
-
88
-
-
0030581151
-
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c
-
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
-
(1996)
Cell
, vol.86
, pp. 147-157
-
-
Liu, X.1
Kim, C.N.2
Yang, J.3
Jemmerson, R.4
Wang, X.5
-
89
-
-
78751511180
-
Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
-
Lock, R., Roy, S., Kenific, C. M., Su, J. S., Salas, E., Ronen, S. M., and Debnath, J. (2011). Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 22, 165-178.
-
(2011)
Mol. Biol. Cell
, vol.22
, pp. 165-178
-
-
Lock, R.1
Roy, S.2
Kenific, C.M.3
Su, J.S.4
Salas, E.5
Ronen, S.M.6
Debnath, J.7
-
90
-
-
0034934743
-
Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance
-
Loggini, B., Rinaldi, I., Pingitore, R., Cristofani, R., Castagna, M., and Barachini, P. (2001). Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance. Tumori 87, 179-186.
-
(2001)
Tumori
, vol.87
, pp. 179-186
-
-
Loggini, B.1
Rinaldi, I.2
Pingitore, R.3
Cristofani, R.4
Castagna, M.5
Barachini, P.6
-
91
-
-
39449093070
-
Caspase activation cascades in apoptosis
-
Logue, S. E., and Martin, S. J. (2008). Caspase activation cascades in apoptosis. Biochem. Soc. Trans. 36, 1-9.
-
(2008)
Biochem. Soc. Trans.
, vol.36
, pp. 1-9
-
-
Logue, S.E.1
Martin, S.J.2
-
92
-
-
57149135309
-
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax
-
Lovell, J. F., Billen, L. P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B., and Andrews, D. W. (2008). Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135, 1074-1084.
-
(2008)
Cell
, vol.135
, pp. 1074-1084
-
-
Lovell, J.F.1
Billen, L.P.2
Bindner, S.3
Shamas-Din, A.4
Fradin, C.5
Leber, B.6
Andrews, D.W.7
-
93
-
-
77952428054
-
Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF
-
Maddodi, N., Huang, W., Havighurst, T., Kim, K., Longley, B. J., and Setaluri, V. (2010). Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J. Invest. Dermatol. 130, 1657-1667.
-
(2010)
J. Invest. Dermatol.
, vol.130
, pp. 1657-1667
-
-
Maddodi, N.1
Huang, W.2
Havighurst, T.3
Kim, K.4
Longley, B.J.5
Setaluri, V.6
-
94
-
-
80052714034
-
BH3 mimetics activate multiple pro-autophagic pathways
-
Malik, S. A., Orhon, I., Morselli, E., Criollo, A., Shen, S., Marino, G., Benyounes, A., Benit, P., Rustin, P., Maiuri, M. C., and Kroemer, G. (2011a). BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 30, 3918-3929.
-
(2011)
Oncogene
, vol.30
, pp. 3918-3929
-
-
Malik, S.A.1
Orhon, I.2
Morselli, E.3
Criollo, A.4
Shen, S.5
Marino, G.6
Benyounes, A.7
Benit, P.8
Rustin, P.9
Maiuri, M.C.10
Kroemer, G.11
-
95
-
-
79961119992
-
BH3 mimetics reveal the network properties of autophagy-regulatory signaling cascades
-
Malik, S. A., Shen, S., Marino, G., BenYounes, A., Maiuri, M. C., and Kroemer, G. (2011b). BH3 mimetics reveal the network properties of autophagy-regulatory signaling cascades. Autophagy 7, 914-916.
-
(2011)
Autophagy
, vol.7
, pp. 914-916
-
-
Malik, S.A.1
Shen, S.2
Marino, G.3
BenYounes, A.4
Maiuri, M.C.5
Kroemer, G.6
-
96
-
-
18444418797
-
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability
-
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., and Fisher, D E. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
-
(2002)
Cell
, vol.109
, pp. 707-718
-
-
McGill, G.G.1
Horstmann, M.2
Widlund, H.R.3
Du, J.4
Motyckova, G.5
Nishimura, E.K.6
Lin, Y.L.7
Ramaswamy, S.8
Avery, W.9
Ding, H.F.10
Jordan, S.A.11
Jackson, I.J.12
Korsmeyer, S.J.13
Golub, T.R.14
Fisher, D.E.15
-
97
-
-
33846465547
-
Immunostimulatory monoclonal antibodies for cancer therapy
-
Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D. M., and Chen, L. (2007). Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 7, 95-106.
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 95-106
-
-
Melero, I.1
Hervas-Stubbs, S.2
Glennie, M.3
Pardoll, D.M.4
Chen, L.5
-
98
-
-
63149186234
-
BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis
-
Miller, L. A., Goldstein, N. B., Johannes, W. U., Walton, C. H., Fujita, M., Norris, D. A., and Shellman, Y. G. (2009). BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. J. Invest. Dermatol. 129, 964-971.
-
(2009)
J. Invest. Dermatol.
, vol.129
, pp. 964-971
-
-
Miller, L.A.1
Goldstein, N.B.2
Johannes, W.U.3
Walton, C.H.4
Fujita, M.5
Norris, D.A.6
Shellman, Y.G.7
-
99
-
-
0031779516
-
Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma
-
Miracco, C., Santopietro, R., Biagioli, M., Lazzi, S., Nyongo, A., Vatti, R., and Luzi, P. (1998). Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma. J. Cutan. Pathol. 25, 244-251.
-
(1998)
J. Cutan. Pathol.
, vol.25
, pp. 244-251
-
-
Miracco, C.1
Santopietro, R.2
Biagioli, M.3
Lazzi, S.4
Nyongo, A.5
Vatti, R.6
Luzi, P.7
-
100
-
-
0029087823
-
bcl-2 expression in melanocytic nevi
-
Morales-Ducret, C. R., van de Rijn, M., and Smoller, B. R. (1995). bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch. Dermatol. 131, 915-918.
-
(1995)
Arch. Dermatol.
, vol.131
, pp. 915-918
-
-
Morales-Ducret, C.R.1
van de Rijn, M.2
Smoller, B.R.3
-
101
-
-
33748360764
-
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci
-
Munshi, A., Tanaka, T., Hobbs, M. L., Tucker, S. L., Richon, V. M., and Meyn, R. E. (2006). Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol. Cancer Ther. 5, 1967-1974.
-
(2006)
Mol. Cancer Ther.
, vol.5
, pp. 1967-1974
-
-
Munshi, A.1
Tanaka, T.2
Hobbs, M.L.3
Tucker, S.L.4
Richon, V.M.5
Meyn, R.E.6
-
102
-
-
0028019746
-
Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria
-
Newmeyer, D. D., Farschon, D. M., and Reed, J. C. (1994). Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353-364.
-
(1994)
Cell
, vol.79
, pp. 353-364
-
-
Newmeyer, D.D.1
Farschon, D.M.2
Reed, J.C.3
-
103
-
-
37649023004
-
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
-
Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Belec, L., Billot, X., Acoca, S., Purisima, E., Wiegmans, A., Cluse, L., Johnstone, R. W., Beauparlant, P., and Shore, G. C. (2007). Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc. Natl. Acad. Sci. U.S.A. 104, 19512-19517.
-
(2007)
Proc. Natl. Acad. Sci. U.S.A.
, vol.104
, pp. 19512-19517
-
-
Nguyen, M.1
Marcellus, R.C.2
Roulston, A.3
Watson, M.4
Serfass, L.5
Murthy Madiraju, S.R.6
Goulet, D.7
Viallet, J.8
Belec, L.9
Billot, X.10
Acoca, S.11
Purisima, E.12
Wiegmans, A.13
Cluse, L.14
Johnstone, R.W.15
Beauparlant, P.16
Shore, G.C.17
-
104
-
-
37649000950
-
Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition
-
Nikiforov, M. A., Riblett, M., Tang, W. H., Gratchouck, V., Zhuang, D., Fernandez, Y., Verhaegen, M., Varambally, S., Chinnaiyan, A. M., Jakubowiak, A. J., and Soengas, M. S. (2007). Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc. Natl. Acad. Sci. U.S.A. 104, 19488-19493.
-
(2007)
Proc. Natl. Acad. Sci. U.S.A.
, vol.104
, pp. 19488-19493
-
-
Nikiforov, M.A.1
Riblett, M.2
Tang, W.H.3
Gratchouck, V.4
Zhuang, D.5
Fernandez, Y.6
Verhaegen, M.7
Varambally, S.8
Chinnaiyan, A.M.9
Jakubowiak, A.J.10
Soengas, M.S.11
-
105
-
-
36849035139
-
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies
-
O'Day, S. J., Hamid, O., and Urba, W. J. (2007). Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies. Cancer 110, 2614-2627.
-
(2007)
Cancer
, vol.110
, pp. 2614-2627
-
-
O'Day, S.J.1
Hamid, O.2
Urba, W.J.3
-
106
-
-
1642633791
-
ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway
-
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Macip, S., Sagara, J., Nakayama, K. I., Aaronson, S. A., and Lee, S. W. (2004). ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat. Cell Biol. 6, 121-128.
-
(2004)
Nat. Cell Biol.
, vol.6
, pp. 121-128
-
-
Ohtsuka, T.1
Ryu, H.2
Minamishima, Y.A.3
Macip, S.4
Sagara, J.5
Nakayama, K.I.6
Aaronson, S.A.7
Lee, S.W.8
-
107
-
-
20444486559
-
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
-
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677-681.
-
(2005)
Nature
, vol.435
, pp. 677-681
-
-
Oltersdorf, T.1
Elmore, S.W.2
Shoemaker, A.R.3
Armstrong, R.C.4
Augeri, D.J.5
Belli, B.A.6
Bruncko, M.7
Deckwerth, T.L.8
Dinges, J.9
Hajduk, P.J.10
Joseph, M.K.11
Kitada, S.12
Korsmeyer, S.J.13
Kunzer, A.R.14
Letai, A.15
Li, C.16
Mitten, M.J.17
Nettesheim, D.G.18
Ng, S.19
Nimmer, P.M.20
O'Connor, J.M.21
Oleksijew, A.22
Petros, A.M.23
Reed, J.C.24
Shen, W.25
Tahir, S.K.26
Thompson, C.B.27
Tomaselli, K.J.28
Wang, B.29
Wendt, M.D.30
Zhang, H.31
Fesik, S.W.32
Rosenberg, S.H.33
more..
-
108
-
-
29144463145
-
The multidomain proapoptotic molecules Bax and Bak are directly activated by heat
-
Pagliari, L. J., Kuwana, T., Bonzon, C., Newmeyer, D. D., Tu, S., Beere, H. M., and Green, D. R. (2005). The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc. Natl. Acad. Sci. U.S.A. 102, 17975-17980.
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 17975-17980
-
-
Pagliari, L.J.1
Kuwana, T.2
Bonzon, C.3
Newmeyer, D.D.4
Tu, S.5
Beere, H.M.6
Green, D.R.7
-
109
-
-
79953325104
-
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression
-
Paraiso, K. H., Xiang, Y., Rebecca, V. W., Abel, E. V., Chen, Y. A., Munko, A. C., Wood, E., Fedorenko, I. V., Sondak, V. K., Anderson, A. R., Ribas, A., Palma, M. D., Nathanson, K. L., Koomen, J. M., Messina, J. L., and Smalley, K. S. (2011). PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res. 71, 2750-2760.
-
(2011)
Cancer Res.
, vol.71
, pp. 2750-2760
-
-
Paraiso, K.H.1
Xiang, Y.2
Rebecca, V.W.3
Abel, E.V.4
Chen, Y.A.5
Munko, A.C.6
Wood, E.7
Fedorenko, I.V.8
Sondak, V.K.9
Anderson, A.R.10
Ribas, A.11
Palma, M.D.12
Nathanson, K.L.13
Koomen, J.M.14
Messina, J.L.15
Smalley, K.S.16
-
110
-
-
79958783120
-
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032)
-
EORTC Melanoma Group.
-
Patel, P. M., Suciu, S., Mortier, L., Kruit, W. H., Robert, C., Schadendorf, D., Trefzer, U., Punt, C. J., Dummer, R., Davidson, N., Becker, J., Conry, R., Thompson, J. A., Hwu, W. J., Engelen, K., Agarwala, S. S., Keilholz, U., Eggermont, A. M., Spatz, A., and EORTC Melanoma Group. (2011). Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). Eur. J. Cancer 47, 1476-1483.
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 1476-1483
-
-
Patel, P.M.1
Suciu, S.2
Mortier, L.3
Kruit, W.H.4
Robert, C.5
Schadendorf, D.6
Trefzer, U.7
Punt, C.J.8
Dummer, R.9
Davidson, N.10
Becker, J.11
Conry, R.12
Thompson, J.A.13
Hwu, W.J.14
Engelen, K.15
Agarwala, S.S.16
Keilholz, U.17
Eggermont, A.M.18
Spatz, A.19
-
111
-
-
19544386831
-
Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis
-
Peltonen, K., Kiviharju, T. M., Jarvinen, P. M., Ra, R., and Laiho, M. (2005). Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. Pigment Cell Res. 18, 196-202.
-
(2005)
Pigment Cell Res.
, vol.18
, pp. 196-202
-
-
Peltonen, K.1
Kiviharju, T.M.2
Jarvinen, P.M.3
Ra, R.4
Laiho, M.5
-
112
-
-
1442310957
-
Structural biology of the Bcl-2 family of proteins
-
Petros, A. M., Olejniczak, E. T., and Fesik, S. W. (2004). Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644, 83-94.
-
(2004)
Biochim. Biophys. Acta
, vol.1644
, pp. 83-94
-
-
Petros, A.M.1
Olejniczak, E.T.2
Fesik, S.W.3
-
113
-
-
0035425425
-
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma
-
Phan, G. Q., Attia, P., Steinberg, S. M., White, D. E., and Rosenberg, S. A. (2001). Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. J. Clin. Oncol. 19, 3477-3482.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 3477-3482
-
-
Phan, G.Q.1
Attia, P.2
Steinberg, S.M.3
White, D.E.4
Rosenberg, S.A.5
-
114
-
-
79953719297
-
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
-
Placzek, W. J., Wei, J., Kitada, S., Zhai, D., Reed, J. C., and Pellecchia, M. (2010). A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis. 1, e40.
-
(2010)
Cell Death Dis.
, vol.1
-
-
Placzek, W.J.1
Wei, J.2
Kitada, S.3
Zhai, D.4
Reed, J.C.5
Pellecchia, M.6
-
115
-
-
0028955865
-
Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture
-
Plettenberg, A., Ballaun, C., Pammer, J., Mildner, M., Strunk, D., Weninger, W., and Tschachler, E. (1995). Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am. J. Pathol. 146, 651-659.
-
(1995)
Am. J. Pathol.
, vol.146
, pp. 651-659
-
-
Plettenberg, A.1
Ballaun, C.2
Pammer, J.3
Mildner, M.4
Strunk, D.5
Weninger, W.6
Tschachler, E.7
-
116
-
-
0036654443
-
A genome-based strategy uncovers frequent BRAF mutations in melanoma
-
Pollock, P. M., and Meltzer, P. S. (2002). A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2, 5-7.
-
(2002)
Cancer Cell
, vol.2
, pp. 5-7
-
-
Pollock, P.M.1
Meltzer, P.S.2
-
117
-
-
69249100500
-
Human caspases: activation, specificity, and regulation
-
Pop, C., and Salvesen, G. S. (2009). Human caspases: activation, specificity, and regulation. J. Biol. Chem. 284, 21777-21781.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 21777-21781
-
-
Pop, C.1
Salvesen, G.S.2
-
118
-
-
79958229709
-
Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-κB-mediated bcl-2 activation
-
Pratheeshkumar, P., and Kuttan, G. (2011a). Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-κB-mediated bcl-2 activation. Drug Chem. Toxicol. 34, 261-270.
-
(2011)
Drug Chem. Toxicol.
, vol.34
, pp. 261-270
-
-
Pratheeshkumar, P.1
Kuttan, G.2
-
119
-
-
79961147781
-
Effect of vernolide-A, a sesquiterpene lactone from Vernonia cinerea L., on cell-mediated immune response in B16F-10 metastatic melanoma-bearing mice
-
Pratheeshkumar, P., and Kuttan, G. (2011b). Effect of vernolide-A, a sesquiterpene lactone from Vernonia cinerea L., on cell-mediated immune response in B16F-10 metastatic melanoma-bearing mice. Immunopharmacol. Immunotoxicol. 33, 533-538.
-
(2011)
Immunopharmacol. Immunotoxicol.
, vol.33
, pp. 533-538
-
-
Pratheeshkumar, P.1
Kuttan, G.2
-
120
-
-
84891603544
-
Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells
-
PMID: 21665879, [Epub ahead of print]
-
Pratheeshkumar, P., Raphael, T. J., and Kuttan, G. (2011). Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells. Integr Cancer Ther. PMID: 21665879. [Epub ahead of print].
-
(2011)
Integr Cancer Ther.
-
-
Pratheeshkumar, P.1
Raphael, T.J.2
Kuttan, G.3
-
121
-
-
77954762634
-
Targeting glutamine metabolism sensitizes melanoma cells to TRAIL-induced death
-
Qin, J. Z., Xin, H., and Nickoloff, B. J. (2010). Targeting glutamine metabolism sensitizes melanoma cells to TRAIL-induced death. Biochem. Biophys. Res. Commun. 398, 146-152.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.398
, pp. 146-152
-
-
Qin, J.Z.1
Xin, H.2
Nickoloff, B.J.3
-
122
-
-
22244452016
-
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells
-
Qin, J. Z., Ziffra, J., Stennett, L., Bodner, B., Bonish, B. K., Chaturvedi, V., Bennett, F., Pollock, P. M., Trent, J. M., Hendrix, M. J., Rizzo, P., Miele, L., and Nickoloff, B. J. (2005). Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res. 65, 6282-6293.
-
(2005)
Cancer Res.
, vol.65
, pp. 6282-6293
-
-
Qin, J.Z.1
Ziffra, J.2
Stennett, L.3
Bodner, B.4
Bonish, B.K.5
Chaturvedi, V.6
Bennett, F.7
Pollock, P.M.8
Trent, J.M.9
Hendrix, M.J.10
Rizzo, P.11
Miele, L.12
Nickoloff, B.J.13
-
123
-
-
0035720233
-
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis
-
Raisova, M., Hossini, A. M., Eberle, J., Riebeling, C., Wieder, T., Sturm, I., Daniel, P. T., Orfanos, C. E., and Geilen, C. C. (2001). The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J. Invest. Dermatol. 117, 333-340.
-
(2001)
J. Invest. Dermatol.
, vol.117
, pp. 333-340
-
-
Raisova, M.1
Hossini, A.M.2
Eberle, J.3
Riebeling, C.4
Wieder, T.5
Sturm, I.6
Daniel, P.T.7
Orfanos, C.E.8
Geilen, C.C.9
-
124
-
-
0028905806
-
bcl-2 protein expression in melanocytic neoplasms of the skin
-
Ramsay, J. A., From, L., and Kahn, H. J. (1995). bcl-2 protein expression in melanocytic neoplasms of the skin. Mod. Pathol. 8, 150-154.
-
(1995)
Mod. Pathol.
, vol.8
, pp. 150-154
-
-
Ramsay, J.A.1
From, L.2
Kahn, H.J.3
-
125
-
-
1342330881
-
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas
-
Reifenberger, J., Knobbe, C. B., Sterzinger, A. A., Blaschke, B., Schulte, K. W., Ruzicka, T., and Reifenberger, G. (2004). Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int. J. Cancer 109, 377-384.
-
(2004)
Int. J. Cancer
, vol.109
, pp. 377-384
-
-
Reifenberger, J.1
Knobbe, C.B.2
Sterzinger, A.A.3
Blaschke, B.4
Schulte, K.W.5
Ruzicka, T.6
Reifenberger, G.7
-
126
-
-
70249083099
-
What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma?
-
Robert, C., and Ghiringhelli, F. (2009). What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma? Oncologist 14, 848-861.
-
(2009)
Oncologist
, vol.14
, pp. 848-861
-
-
Robert, C.1
Ghiringhelli, F.2
-
127
-
-
79959772576
-
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
-
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., M, D. J., Garbe, C., Lebbe, C., Baurain, J. F., Testori, A., Grob, J. J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W. H. Jr., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R., Francis, S., Chen, T. T., Humphrey, R., Hoos, A., and Wolchok, J. D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl. J. Med. 364, 2517-2526.
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 2517-2526
-
-
Robert, C.1
Thomas, L.2
Bondarenko, I.3
O'Day, S.M.D.J.4
Garbe, C.5
Lebbe, C.6
Baurain, J.F.7
Testori, A.8
Grob, J.J.9
Davidson, N.10
Richards, J.11
Maio, M.12
Hauschild, A.13
Miller Jr., W.H.14
Gascon, P.15
Lotem, M.16
Harmankaya, K.17
Ibrahim, R.18
Francis, S.19
Chen, T.T.20
Humphrey, R.21
Hoos, A.22
Wolchok, J.D.23
more..
-
128
-
-
77955616572
-
Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes
-
Ryan, J. A., Brunelle, J. K., and Letai, A. (2010). Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes. Proc. Natl. Acad. Sci. U.S.A. 107, 12895-12900.
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 12895-12900
-
-
Ryan, J.A.1
Brunelle, J.K.2
Letai, A.3
-
129
-
-
0027998115
-
Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi
-
Saenz-Santamaria, M. C., Reed, J. A., McNutt, N. S., and Shea, C. R. (1994). Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi. J. Cutan. Pathol. 21, 393-397.
-
(1994)
J. Cutan. Pathol.
, vol.21
, pp. 393-397
-
-
Saenz-Santamaria, M.C.1
Reed, J.A.2
McNutt, N.S.3
Shea, C.R.4
-
130
-
-
77950205394
-
The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack
-
Seeger, J. M., Schmidt, P., Brinkmann, K., Hombach, A. A., Coutelle, O., Zigrino, P., Wagner-Stippich, D., Mauch, C., Abken, H., Kronke, M., and Kashkar, H. (2010). The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack. Cancer Res. 70, 1825-1834.
-
(2010)
Cancer Res.
, vol.70
, pp. 1825-1834
-
-
Seeger, J.M.1
Schmidt, P.2
Brinkmann, K.3
Hombach, A.A.4
Coutelle, O.5
Zigrino, P.6
Wagner-Stippich, D.7
Mauch, C.8
Abken, H.9
Kronke, M.10
Kashkar, H.11
-
131
-
-
0019204729
-
DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma
-
Seigler, H. F., Lucas, V. S. Jr., Pickett, N. J., and Huang, A. T. (1980). DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma. Cancer 46, 2346-2348.
-
(1980)
Cancer
, vol.46
, pp. 2346-2348
-
-
Seigler, H.F.1
Lucas Jr., V.S.2
Pickett, N.J.3
Huang, A.T.4
-
132
-
-
0031838967
-
Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
-
Selzer, E., Schlagbauer-Wadl, H., Okamoto, I., Pehamberger, H., Potter, R., and Jansen, B. (1998). Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res. 8, 197-203.
-
(1998)
Melanoma Res.
, vol.8
, pp. 197-203
-
-
Selzer, E.1
Schlagbauer-Wadl, H.2
Okamoto, I.3
Pehamberger, H.4
Potter, R.5
Jansen, B.6
-
133
-
-
77955757007
-
Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells
-
Shao, Y., and Aplin, A. E. (2010). Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells. Cancer Res. 70, 6670-6681.
-
(2010)
Cancer Res.
, vol.70
, pp. 6670-6681
-
-
Shao, Y.1
Aplin, A.E.2
-
134
-
-
52049084154
-
Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim
-
Sheridan, C., Brumatti, G., and Martin, S. J. (2008). Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim. J. Biol. Chem. 283, 22128-22135.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 22128-22135
-
-
Sheridan, C.1
Brumatti, G.2
Martin, S.J.3
-
135
-
-
0142120662
-
Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins
-
Shibuya, H., Kato, Y., Saito, M., Isobe, T., Tsuboi, R., Koga, M., Toyota, H., and Mizuguchi, J. (2003). Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins. Melanoma Res. 13, 457-464.
-
(2003)
Melanoma Res.
, vol.13
, pp. 457-464
-
-
Shibuya, H.1
Kato, Y.2
Saito, M.3
Isobe, T.4
Tsuboi, R.5
Koga, M.6
Toyota, H.7
Mizuguchi, J.8
-
136
-
-
0024819304
-
ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development
-
Shukla, V. K., Hughes, D. C., Hughes, L. E., McCormick, F., and Padua, R. A. (1989). ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development. Oncogene Res. 5, 121-127.
-
(1989)
Oncogene Res.
, vol.5
, pp. 121-127
-
-
Shukla, V.K.1
Hughes, D.C.2
Hughes, L.E.3
McCormick, F.4
Padua, R.A.5
-
137
-
-
0038793948
-
Apoptosis and melanoma chemoresistance
-
Soengas, M. S., and Lowe, S. W. (2003). Apoptosis and melanoma chemoresistance. Oncogene 22, 3138-3151.
-
(2003)
Oncogene
, vol.22
, pp. 3138-3151
-
-
Soengas, M.S.1
Lowe, S.W.2
-
138
-
-
4944249733
-
Deregulated Akt3 activity promotes development of malignant melanoma
-
Stahl, J. M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J. Q., Bosenberg, M. W., Kester, M., Sandirasegarane, L., and Robertson, G. P. (2004). Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64, 7002-7010.
-
(2004)
Cancer Res.
, vol.64
, pp. 7002-7010
-
-
Stahl, J.M.1
Sharma, A.2
Cheung, M.3
Zimmerman, M.4
Cheng, J.Q.5
Bosenberg, M.W.6
Kester, M.7
Sandirasegarane, L.8
Robertson, G.P.9
-
139
-
-
17144436629
-
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
-
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H., and Tavtigian, S. V. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362.
-
(1997)
Nat. Genet.
, vol.15
, pp. 356-362
-
-
Steck, P.A.1
Pershouse, M.A.2
Jasser, S.A.3
Yung, W.K.4
Lin, H.5
Ligon, A.H.6
Langford, L.A.7
Baumgard, M.L.8
Hattier, T.9
Davis, T.10
Frye, C.11
Hu, R.12
Swedlund, B.13
Teng, D.H.14
Tavtigian, S.V.15
-
140
-
-
44449116729
-
Treatment approaches for advanced cutaneous melanoma
-
Stein, J. A., and Brownell, I. (2008). Treatment approaches for advanced cutaneous melanoma. J. Drugs Dermatol. 7, 175-179.
-
(2008)
J. Drugs Dermatol.
, vol.7
, pp. 175-179
-
-
Stein, J.A.1
Brownell, I.2
-
141
-
-
77955891885
-
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
-
Stewart, M. L., Fire, E., Keating, A. E., and Walensky, L. D. (2010). The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer. Nat. Chem. Biol. 6, 595-601.
-
(2010)
Nat. Chem. Biol.
, vol.6
, pp. 595-601
-
-
Stewart, M.L.1
Fire, E.2
Keating, A.E.3
Walensky, L.D.4
-
142
-
-
0036224150
-
Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma
-
Sviatoha, V., Rundgren, A., Tani, E., Hansson, J., Kleina, R., and Skoog, L. (2002). Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma. Cytopathology 13, 11-21.
-
(2002)
Cytopathology
, vol.13
, pp. 11-21
-
-
Sviatoha, V.1
Rundgren, A.2
Tani, E.3
Hansson, J.4
Kleina, R.5
Skoog, L.6
-
143
-
-
0030804939
-
Anti-cell death activity promotes pulmonary metastasis of melanoma cells
-
Takaoka, A., Adachi, M., Okuda, H., Sato, S., Yawata, A., Hinoda, Y., Takayama, S., Reed, J. C., and Imai, K. (1997). Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14, 2971-2977.
-
(1997)
Oncogene
, vol.14
, pp. 2971-2977
-
-
Takaoka, A.1
Adachi, M.2
Okuda, H.3
Sato, S.4
Yawata, A.5
Hinoda, Y.6
Takayama, S.7
Reed, J.C.8
Imai, K.9
-
144
-
-
0035951847
-
MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains
-
Tan, K. O., Tan, K. M., Chan, S. L., Yee, K. S., Bevort, M., Ang, K. C., and Yu, V. C. (2001). MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. J. Biol. Chem. 276, 2802-2807.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 2802-2807
-
-
Tan, K.O.1
Tan, K.M.2
Chan, S.L.3
Yee, K.S.4
Bevort, M.5
Ang, K.C.6
Yu, V.C.7
-
145
-
-
0031850559
-
Expression of apoptosis regulators in cutaneous malignant melanoma
-
Tang, L., Tron, V. A., Reed, J. C., Mah, K. J., Krajewska, M., Li, G., Zhou, X., Ho, V. C., and Trotter, M. J. (1998). Expression of apoptosis regulators in cutaneous malignant melanoma. Clin. Cancer Res. 4, 1865-1871.
-
(1998)
Clin. Cancer Res.
, vol.4
, pp. 1865-1871
-
-
Tang, L.1
Tron, V.A.2
Reed, J.C.3
Mah, K.J.4
Krajewska, M.5
Li, G.6
Zhou, X.7
Ho, V.C.8
Trotter, M.J.9
-
146
-
-
33846921781
-
Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings
-
Tchernev, G., and Orfanos, C. E. (2007). Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. J. Cutan. Pathol. 34, 247-256.
-
(2007)
J. Cutan. Pathol.
, vol.34
, pp. 247-256
-
-
Tchernev, G.1
Orfanos, C.E.2
-
147
-
-
0038806293
-
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model
-
Thallinger, C., Wolschek, M. F., Wacheck, V., Maierhofer, H., Gunsberg, P., Polterauer, P., Pehamberger, H., Monia, B. P., Selzer, E., Wolff, K., and Jansen, B. (2003). Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. J. Invest. Dermatol. 120, 1081-1086.
-
(2003)
J. Invest. Dermatol.
, vol.120
, pp. 1081-1086
-
-
Thallinger, C.1
Wolschek, M.F.2
Wacheck, V.3
Maierhofer, H.4
Gunsberg, P.5
Polterauer, P.6
Pehamberger, H.7
Monia, B.P.8
Selzer, E.9
Wolff, K.10
Jansen, B.11
-
148
-
-
47949086963
-
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development
-
Tran, M. A., Smith, C. D., Kester, M., and Robertson, G. P. (2008). Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin. Cancer Res. 14, 3571-3581.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 3571-3581
-
-
Tran, M.A.1
Smith, C.D.2
Kester, M.3
Robertson, G.P.4
-
149
-
-
0028934199
-
Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma
-
Tron, V. A., Krajewski, S., Klein-Parker, H., Li, G., Ho, V. C., and Reed, J. C. (1995). Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am. J. Pathol. 146, 643-650.
-
(1995)
Am. J. Pathol.
, vol.146
, pp. 643-650
-
-
Tron, V.A.1
Krajewski, S.2
Klein-Parker, H.3
Li, G.4
Ho, V.C.5
Reed, J.C.6
-
150
-
-
34249982915
-
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
-
Trudel, S., Li, Z. H., Rauw, J., Tiedemann, R. E., Wen, X. Y., and Stewart, A. K. (2007). Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma. Blood 109, 5430-5438.
-
(2007)
Blood
, vol.109
, pp. 5430-5438
-
-
Trudel, S.1
Li, Z.H.2
Rauw, J.3
Tiedemann, R.E.4
Wen, X.Y.5
Stewart, A.K.6
-
151
-
-
4344656396
-
Management of cutaneous melanoma
-
Tsao, H., Atkins, M. B., and Sober, A. J. (2004). Management of cutaneous melanoma. N. Engl. J. Med. 351, 998-1012.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 998-1012
-
-
Tsao, H.1
Atkins, M.B.2
Sober, A.J.3
-
152
-
-
0032474749
-
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
-
Tsao, H., Zhang, X., Benoit, E., and Haluska, F. G. (1998). Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16, 3397-3402.
-
(1998)
Oncogene
, vol.16
, pp. 3397-3402
-
-
Tsao, H.1
Zhang, X.2
Benoit, E.3
Haluska, F.G.4
-
153
-
-
0034085811
-
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines
-
Tsao, H., Zhang, X., Fowlkes, K., and Haluska, F. G. (2000). Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res. 60, 1800-1804.
-
(2000)
Cancer Res.
, vol.60
, pp. 1800-1804
-
-
Tsao, H.1
Zhang, X.2
Fowlkes, K.3
Haluska, F.G.4
-
154
-
-
0036421606
-
Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma
-
Utikal, J., Leiter, U., Udart, M., Kaskel, P., Peter, R. U., and Krahn, G. M. (2002). Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma. Cancer Invest. 20, 914-921.
-
(2002)
Cancer Invest.
, vol.20
, pp. 914-921
-
-
Utikal, J.1
Leiter, U.2
Udart, M.3
Kaskel, P.4
Peter, R.U.5
Krahn, G.M.6
-
155
-
-
76349100965
-
SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells
-
Vachtenheim, J., Ondrusova, L., and Borovansky, J. (2010). SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells. Biochem. Biophys. Res. Commun. 392, 454-459.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.392
, pp. 454-459
-
-
Vachtenheim, J.1
Ondrusova, L.2
Borovansky, J.3
-
156
-
-
62449193810
-
Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma
-
VanBrocklin, M. W., Verhaegen, M., Soengas, M. S., and Holmen, S. L. (2009). Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. Cancer Res. 69, 1985-1994.
-
(2009)
Cancer Res.
, vol.69
, pp. 1985-1994
-
-
VanBrocklin, M.W.1
Verhaegen, M.2
Soengas, M.S.3
Holmen, S.L.4
-
157
-
-
33845797913
-
A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species
-
Verhaegen, M., Bauer, J. A., Martin de la Vega, C., Wang, G., Wolter, K. G., Brenner, J. C., Nikolovska-Coleska, Z., Bengtson, A., Nair, R., Elder, J. T., Van Brocklin, M., Carey, T. E., Bradford, C. R., Wang, S., and Soengas, M. S. (2006). A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Res. 66, 11348-11359.
-
(2006)
Cancer Res.
, vol.66
, pp. 11348-11359
-
-
Verhaegen, M.1
Bauer, J.A.2
Martin de la Vega, C.3
Wang, G.4
Wolter, K.G.5
Brenner, J.C.6
Nikolovska-Coleska, Z.7
Bengtson, A.8
Nair, R.9
Elder, J.T.10
Van Brocklin, M.11
Carey, T.E.12
Bradford, C.R.13
Wang, S.14
Soengas, M.S.15
-
159
-
-
0037023712
-
SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)
-
Vucic, D., Deshayes, K., Ackerly, H., Pisabarro, M. T., Kadkhodayan, S., Fairbrother, W. J., and Dixit, V. M. (2002). SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J. Biol. Chem. 277, 12275-12279.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 12275-12279
-
-
Vucic, D.1
Deshayes, K.2
Ackerly, H.3
Pisabarro, M.T.4
Kadkhodayan, S.5
Fairbrother, W.J.6
Dixit, V.M.7
-
160
-
-
4444291734
-
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
-
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., and Korsmeyer, S. J. (2004). Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305, 1466-1470.
-
(2004)
Science
, vol.305
, pp. 1466-1470
-
-
Walensky, L.D.1
Kung, A.L.2
Escher, I.3
Malia, T.J.4
Barbuto, S.5
Wright, R.D.6
Wagner, G.7
Verdine, G.L.8
Korsmeyer, S.J.9
-
161
-
-
33749660845
-
A stapled BID BH3 helix directly binds and activates BAX
-
Walensky, L. D., Pitter, K., Morash, J., Oh, K. J., Barbuto, S., Fisher, J., Smith, E., Verdine, G. L., and Korsmeyer, S. J. (2006). A stapled BID BH3 helix directly binds and activates BAX. Mol. Cell 24, 199-210.
-
(2006)
Mol. Cell
, vol.24
, pp. 199-210
-
-
Walensky, L.D.1
Pitter, K.2
Morash, J.3
Oh, K.J.4
Barbuto, S.5
Fisher, J.6
Smith, E.7
Verdine, G.L.8
Korsmeyer, S.J.9
-
162
-
-
12144289677
-
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
-
Cancer Genome Project.
-
Wan, P. T., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Jones, C. M., Marshall, C. J., Springer, C. J., Barford, D., Marais, R., and Cancer Genome Project. (2004). Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867.
-
(2004)
Cell
, vol.116
, pp. 855-867
-
-
Wan, P.T.1
Garnett, M.J.2
Roe, S.M.3
Lee, S.4
Niculescu-Duvaz, D.5
Good, V.M.6
Jones, C.M.7
Marshall, C.J.8
Springer, C.J.9
Barford, D.10
Marais, R.11
-
163
-
-
34548096400
-
Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1
-
Wang, Y. F., Jiang, C. C., Kiejda, K. A., Gillespie, S., Zhang, X. D., and Hersey, P. (2007). Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin. Cancer Res. 13, 4934-4942.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 4934-4942
-
-
Wang, Y.F.1
Jiang, C.C.2
Kiejda, K.A.3
Gillespie, S.4
Zhang, X.D.5
Hersey, P.6
-
164
-
-
77952575844
-
Endogenous noxa determines the strong proapoptotic synergism of the BH3-mimetic ABT-737 with chemotherapeutic agents in human melanoma cells
-
Weber, A., Kirejczyk, Z., Potthoff, S., Ploner, C., and Hacker, G. (2009). Endogenous noxa determines the strong proapoptotic synergism of the BH3-mimetic ABT-737 with chemotherapeutic agents in human melanoma cells. Transl. Oncol. 2, 73-83.
-
(2009)
Transl. Oncol.
, vol.2
, pp. 73-83
-
-
Weber, A.1
Kirejczyk, Z.2
Potthoff, S.3
Ploner, C.4
Hacker, G.5
-
165
-
-
0034663829
-
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
-
Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., and Korsmeyer, S. J. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071.
-
(2000)
Genes Dev.
, vol.14
, pp. 2060-2071
-
-
Wei, M.C.1
Lindsten, T.2
Mootha, V.K.3
Weiler, S.4
Gross, A.5
Ashiya, M.6
Thompson, C.B.7
Korsmeyer, S.J.8
-
166
-
-
0035957653
-
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death
-
Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., and Korsmeyer, S. J. (2001). Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730.
-
(2001)
Science
, vol.292
, pp. 727-730
-
-
Wei, M.C.1
Zong, W.X.2
Cheng, E.H.3
Lindsten, T.4
Panoutsakopoulou, V.5
Ross, A.J.6
Roth, K.A.7
MacGregor, G.R.8
Thompson, C.B.9
Korsmeyer, S.J.10
-
167
-
-
22244464818
-
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
-
Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M., and Huang, D. C. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19, 1294-1305.
-
(2005)
Genes Dev.
, vol.19
, pp. 1294-1305
-
-
Willis, S.N.1
Chen, L.2
Dewson, G.3
Wei, A.4
Naik, E.5
Fletcher, J.I.6
Adams, J.M.7
Huang, D.C.8
-
168
-
-
33846964621
-
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
-
Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., Ierino, H., Lee, E. F., Fairlie, W. D., Bouillet, P., Strasser, A., Kluck, R. M., Adams, J. M., and Huang, D. C. (2007). Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856-859.
-
(2007)
Science
, vol.315
, pp. 856-859
-
-
Willis, S.N.1
Fletcher, J.I.2
Kaufmann, T.3
van Delft, M.F.4
Chen, L.5
Czabotar, P.E.6
Ierino, H.7
Lee, E.F.8
Fairlie, W.D.9
Bouillet, P.10
Strasser, A.11
Kluck, R.M.12
Adams, J.M.13
Huang, D.C.14
-
169
-
-
43849086306
-
Myeloid leukemia-1 expression in benign and malignant melanocytic lesions
-
Wong, R. P., Khosravi, S., Martinka, M., and Li, G. (2008). Myeloid leukemia-1 expression in benign and malignant melanocytic lesions. Oncol. Rep. 19, 933-937.
-
(2008)
Oncol. Rep.
, vol.19
, pp. 933-937
-
-
Wong, R.P.1
Khosravi, S.2
Martinka, M.3
Li, G.4
-
170
-
-
0030864875
-
Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2
-
Xie, K., Wang, Y., Huang, S., Xu, L., Bielenberg, D., Salas, T., McConkey, D. J., Jiang, W., and Fidler, I. J. (1997). Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2. Oncogene 15, 771-779.
-
(1997)
Oncogene
, vol.15
, pp. 771-779
-
-
Xie, K.1
Wang, Y.2
Huang, S.3
Xu, L.4
Bielenberg, D.5
Salas, T.6
McConkey, D.J.7
Jiang, W.8
Fidler, I.J.9
-
171
-
-
59149095869
-
Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells
-
Xu, X., Liu, Y., Wang, L., He, J., Zhang, H., Chen, X., Li, Y., Yang, J., and Tao, J. (2009). Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. Int. J. Dermatol. 48, 186-192.
-
(2009)
Int. J. Dermatol.
, vol.48
, pp. 186-192
-
-
Xu, X.1
Liu, Y.2
Wang, L.3
He, J.4
Zhang, H.5
Chen, X.6
Li, Y.7
Yang, J.8
Tao, J.9
-
172
-
-
0029681851
-
Accelerated disappearance of melanocytes in bcl-2-deficient mice
-
Yamamura, K., Kamada, S., Ito, S., Nakagawa, K., Ichihashi, M., and Tsujimoto, Y. (1996). Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res. 56, 3546-3550.
-
(1996)
Cancer Res.
, vol.56
, pp. 3546-3550
-
-
Yamamura, K.1
Kamada, S.2
Ito, S.3
Nakagawa, K.4
Ichihashi, M.5
Tsujimoto, Y.6
-
173
-
-
77951442337
-
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
-
Yecies, D., Carlson, N. E., Deng, J., and Letai, A. (2010). Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood 115, 3304-3313.
-
(2010)
Blood
, vol.115
, pp. 3304-3313
-
-
Yecies, D.1
Carlson, N.E.2
Deng, J.3
Letai, A.4
-
174
-
-
77950501356
-
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines
-
You, M., Savaraj, N., Wangpaichitr, M., Wu, C., Kuo, M. T., Varona-Santos, J., Nguyen, D. M., and Feun, L. (2010). The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines. Biochem. Biophys. Res. Commun. 394, 760-766.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.394
, pp. 760-766
-
-
You, M.1
Savaraj, N.2
Wangpaichitr, M.3
Wu, C.4
Kuo, M.T.5
Varona-Santos, J.6
Nguyen, D.M.7
Feun, L.8
-
175
-
-
33750548225
-
Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent phenoxodiol-induced apoptosis of human melanoma cells
-
Yu, F., Watts, R. N., Zhang, X. D., Borrow, J. M., and Hersey, P. (2006). Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent phenoxodiol-induced apoptosis of human melanoma cells. Anticancer Drugs 17, 1151-1161.
-
(2006)
Anticancer Drugs
, vol.17
, pp. 1151-1161
-
-
Yu, F.1
Watts, R.N.2
Zhang, X.D.3
Borrow, J.M.4
Hersey, P.5
-
176
-
-
77955642515
-
The protease inhibitor, elafin, induces p53-dependent apoptosis in human melanoma cells
-
Yu, K. S., Lee, Y., Kim, C. M., Park, E. C., Choi, J., Lim, D. S., Chung, Y. H., and Koh, S. S. (2010). The protease inhibitor, elafin, induces p53-dependent apoptosis in human melanoma cells. Int. J. Cancer 127, 1308-1320.
-
(2010)
Int. J. Cancer
, vol.127
, pp. 1308-1320
-
-
Yu, K.S.1
Lee, Y.2
Kim, C.M.3
Park, E.C.4
Choi, J.5
Lim, D.S.6
Chung, Y.H.7
Koh, S.S.8
-
177
-
-
33645235858
-
Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis
-
Zhang, H., and Rosdahl, I. (2006). Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis. Int. J. Oncol. 28, 661-666.
-
(2006)
Int. J. Oncol.
, vol.28
, pp. 661-666
-
-
Zhang, H.1
Rosdahl, I.2
-
178
-
-
72549088701
-
Diallyl trisulphide-induced apoptosis in human melanoma cells involves downregulation of Bcl-2 and Bcl-xL expression and activation of caspases
-
Zhou, C., Mao, X. P., Guo, Q., and Zeng, F. Q. (2009). Diallyl trisulphide-induced apoptosis in human melanoma cells involves downregulation of Bcl-2 and Bcl-xL expression and activation of caspases. Clin. Exp. Dermatol. 34, e537-e543.
-
(2009)
Clin. Exp. Dermatol.
, vol.34
-
-
Zhou, C.1
Mao, X.P.2
Guo, Q.3
Zeng, F.Q.4
-
179
-
-
0033819340
-
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
-
Zhou, X. P., Gimm, O., Hampel, H., Niemann, T., Walker, M. J., and Eng, C. (2000). Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am. J. Pathol. 157, 1123-1128.
-
(2000)
Am. J. Pathol.
, vol.157
, pp. 1123-1128
-
-
Zhou, X.P.1
Gimm, O.2
Hampel, H.3
Niemann, T.4
Walker, M.J.5
Eng, C.6
-
180
-
-
73949089935
-
Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins
-
Zhuang, L., Scolyer, R. A., Murali, R., McCarthy, S. W., Zhang, X. D., Thompson, J. F., and Hersey, P. (2010). Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Mod. Pathol. 23, 45-53.
-
(2010)
Mod. Pathol.
, vol.23
, pp. 45-53
-
-
Zhuang, L.1
Scolyer, R.A.2
Murali, R.3
McCarthy, S.W.4
Zhang, X.D.5
Thompson, J.F.6
Hersey, P.7
-
181
-
-
37749037799
-
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs
-
Zobel, K., Wang, L., Varfolomeev, E., Franklin, M. C., Elliott, L. O., Wallweber, H. J., Okawa, D. C., Flygare, J. A., Vucic, D., Fairbrother, W. J., and Deshayes, K. (2006). Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. ACS Chem. Biol. 1, 525-533.
-
(2006)
ACS Chem. Biol.
, vol.1
, pp. 525-533
-
-
Zobel, K.1
Wang, L.2
Varfolomeev, E.3
Franklin, M.C.4
Elliott, L.O.5
Wallweber, H.J.6
Okawa, D.C.7
Flygare, J.A.8
Vucic, D.9
Fairbrother, W.J.10
Deshayes, K.11
-
182
-
-
0030745646
-
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
-
Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
-
(1997)
Cell
, vol.90
, pp. 405-413
-
-
Zou, H.1
Henzel, W.J.2
Liu, X.3
Lutschg, A.4
Wang, X.5
|